ASX Health Stocks: LBT skyrockets 40pc after winning deal with global pharma, AstraZeneca
LBT Innovations has secured a major deal with AstraZeneca Arovella has received positive pre-IND feedback from the FDA for its ALA-101 therapy Amplia has been granted key patents in Japan and Europe for narmafotinib LBT announces big deal with …